Literature DB >> 18627265

Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice.

Rachel A Davey1, Andrew G Turner, Julie F McManus, W S Maria Chiu, Francisca Tjahyono, Alison J Moore, Gerald J Atkins, Paul H Anderson, Cathy Ma, Vaida Glatt, Helen E MacLean, Cristina Vincent, Mary Bouxsein, Howard A Morris, David M Findlay, Jeffrey D Zajac.   

Abstract

It is well established that calcitonin is a potent inhibitor of bone resorption; however, a physiological role for calcitonin acting through its cognate receptor, the calcitonin receptor (CTR), has not been identified. Data from previous genetically modified animal models have recognized a possible role for calcitonin and the CTR in controlling bone formation; however, interpretation of these data are complicated, in part because of their mixed genetic background. Therefore, to elucidate the physiological role of the CTR in calcium and bone metabolism, we generated a viable global CTR knockout (KO) mouse model using the Cre/loxP system, in which the CTR is globally deleted by >94% but <100%. Global CTRKOs displayed normal serum ultrafiltrable calcium levels and a mild increase in bone formation in males, showing that the CTR plays a modest physiological role in the regulation of bone and calcium homeostasis in the basal state in mice. Furthermore, the peak in serum total calcium after calcitriol [1,25(OH)(2)D(3)]-induced hypercalcemia was substantially greater in global CTRKOs compared with controls. These data provide strong evidence for a biological role of the CTR in regulating calcium homeostasis in states of calcium stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627265      PMCID: PMC2680171          DOI: 10.1359/jbmr.080310

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  39 in total

1.  The deletion of 14 amino acids in the seventh transmembrane domain of a naturally occurring calcitonin receptor isoform alters ligand binding and selectively abolishes coupling to phospholipase C.

Authors:  J F Shyu; D Inoue; R Baron; W C Horne
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

Review 2.  Thyrocalcitonin.

Authors:  P F Hirsch; P L Munson
Journal:  Physiol Rev       Date:  1969-07       Impact factor: 37.312

3.  The acute effects of porcine calcitonin in man.

Authors:  T J Martin; R A Melick
Journal:  Australas Ann Med       Date:  1969-08

4.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.

Authors:  F Schwenk; U Baron; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

5.  Calcitonin alters behaviour of isolated osteoclasts.

Authors:  T J Chambers; C J Magnus
Journal:  J Pathol       Date:  1982-01       Impact factor: 7.996

6.  Effects of oophorectomy on biochemical and bone variables in the rat.

Authors:  H A Morris; S J Porter; T C Durbridge; R J Moore; A G Need; B E Nordin
Journal:  Bone Miner       Date:  1992-08

Review 7.  Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance.

Authors:  F R Singer; R S Fredericks; C Minkin
Journal:  Arthritis Rheum       Date:  1980-10

8.  Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene.

Authors:  J E Garrett; H Tamir; O Kifor; R T Simin; K V Rogers; A Mithal; R F Gagel; E M Brown
Journal:  Endocrinology       Date:  1995-11       Impact factor: 4.736

9.  Endogenous calcitonin attenuates parathyroid hormone-induced cancellous bone loss in the rat.

Authors:  M Yamamoto; J G Seedor; G A Rodan; R Balena
Journal:  Endocrinology       Date:  1995-02       Impact factor: 4.736

10.  Genetic variability in adult bone density among inbred strains of mice.

Authors:  W G Beamer; L R Donahue; C J Rosen; D J Baylink
Journal:  Bone       Date:  1996-05       Impact factor: 4.398

View more
  23 in total

1.  Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual.

Authors:  Rachel A Davey; Michele V Clarke; Stephen Sastra; Jarrod P Skinner; Cherie Chiang; Paul H Anderson; Jeffrey D Zajac
Journal:  Transgenic Res       Date:  2011-12-13       Impact factor: 2.788

Review 2.  GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities.

Authors:  Jonathan D Roth; Mary R Erickson; Steve Chen; David G Parkes
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss.

Authors:  Julia Barsony; Yoshihisa Sugimura; Joseph G Verbalis
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

4.  Fracture, bone mineral density, and the effects of calcitonin receptor gene in postmenopausal Koreans.

Authors:  H-J Lee; S-Y Kim; G S Kim; J-Y Hwang; Y-J Kim; B Jeong; T-H Kim; E K Park; S H Lee; H-L Kim; J-M Koh; J-Y Lee
Journal:  Osteoporos Int       Date:  2009-11-28       Impact factor: 4.507

5.  The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaque.

Authors:  Peter J Wookey; Anthony Zulli; David L Hare
Journal:  Histochem Cell Biol       Date:  2009-04-29       Impact factor: 4.304

6.  Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms.

Authors:  Jackie M Y How; Suhail A Wardak; Shaik I Ameer; Rachel A Davey; Daniela M Sartor
Journal:  J Physiol       Date:  2014-02-03       Impact factor: 5.182

7.  Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis.

Authors:  Brian Ell; Laura Mercatali; Toni Ibrahim; Neil Campbell; Heidi Schwarzenbach; Klaus Pantel; Dino Amadori; Yibin Kang
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

8.  Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis.

Authors:  Max D Kauther; Hagen S Bachmann; Laura Neuerburg; Martina Broecker-Preuss; Gero Hilken; Florian Grabellus; Gabriele Koehler; Marius von Knoch; Christian Wedemeyer
Journal:  BMC Musculoskelet Disord       Date:  2011-08-15       Impact factor: 2.362

9.  Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis.

Authors:  Yi-Jie Kuo; Fon-Yih Tsuang; Jui-Sheng Sun; Chi-Hung Lin; Chia-Hsien Chen; Jia-Ying Li; Yi-Chian Huang; Wei-Yu Chen; Chin-Bin Yeh; Jia-Fwu Shyu
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

10.  Inhibition of miR-29 Activity in the Myeloid Lineage Increases Response to Calcitonin and Trabecular Bone Volume in Mice.

Authors:  Bongjin Shin; Henry C Hrdlicka; Anne M Delany; Sun-Kyeong Lee
Journal:  Endocrinology       Date:  2021-10-01       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.